Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02160964
Other study ID # PC14-0610-002
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 7, 2014
Last updated March 18, 2015
Start date May 2015
Est. completion date January 2017

Study information

Verified date March 2015
Source Heart and Vascular Outcomes Research Institute
Contact Uchenna N Onyeachom
Email uonyeachom@hvori.org
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

Since 2003, that the first retrievable IVC filter was introduced in the U.S,improvements have been made in the filter design to resolve problems of structural integrity and increase the ability to remove the filter after longer periods of time.The FDA issued a communication in August 2010 advising physicians to remove retrievable filters whenever possible and updated that letter again in May 2014 due to concerns that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient's risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.


Description:

Several studies have shown that approximately 80% to 85% of optional IVC filters are never retrieved. The successful removal of retrievable filters requires diligent patient follow-up and interdepartmental cooperation, and even so, successful removal is not always possible. American College of Chest Physicians (ACCP) guidelines for IVCF placement indications advocates a close, structured follow-up of retrievable IVCFs to improve filter retrieval rates.

Using a retrieval algorithm and pathway program, a score will trigger a secure email and text messages sent to both physician and patient at different timelines, for follow up so as to retrieve filter placed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1786
Est. completion date January 2017
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Data obtained in line with good clinical practice, applicable laws and regulation

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Heart and Vascular Outcomes Research Institute

Outcome

Type Measure Description Time frame Safety issue
Primary Filter retrieval rate 24 Months No
Secondary Absence of major adverse event 24 Months Yes